NCT03586050View on ClinicalTrials.gov

Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 11, 2017

Primary Completion Date

May 21, 2020

Study Completion Date

May 11, 2023

Conditions
Carcinoma, HepatocellularHepatocellular CarcinomaHepatocellular CancerCancer, Hepatocellular
Interventions
DEVICE

Microwave ablation

All patients will receive microwave ablation using the NeuWave Microwave Ablation System and Accessories

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Ethicon, Inc.

INDUSTRY

NCT03586050 - Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea | Biotech Hunter | Biotech Hunter